Literature DB >> 10520473

Use of the case-control approach in vaccine evaluation: efficacy and adverse effects.

L C Rodrigues1, P G Smith.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10520473     DOI： 10.1093/oxfordjournals.epirev.a017988

Source DB:  PubMed          Journal:  Epidemiol Rev        ISSN： 0193-936X            Impact factor:   6.222


× No keyword cloud information.
  19 in total

Review 1.  Vaccine trials.

Authors:  C P Farrington; E Miller
Journal:  Mol Biotechnol       Date:  2001-01       Impact factor: 2.695

Review 2.  Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications.

Authors:  E Hak; Th J M Verheij; D E Grobbee; K L Nichol; A W Hoes
Journal:  J Epidemiol Community Health       Date:  2002-12       Impact factor: 3.710

3.  Measurement of Vaccine Direct Effects Under the Test-Negative Design.

Authors:  Joseph A Lewnard; Christine Tedijanto; Benjamin J Cowling; Marc Lipsitch
Journal:  Am J Epidemiol       Date:  2018-12-01       Impact factor: 4.897

4.  Prediction of pneumococcal conjugate vaccine effectiveness against invasive pneumococcal disease using opsonophagocytic activity and antibody concentrations determined by enzyme-linked immunosorbent assay with 22F adsorption.

Authors:  L Schuerman; J Wysocki; J C Tejedor; M Knuf; K-H Kim; J Poolman
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

5.  Impact and effectiveness of a conjugate vaccine against invasive pneumococcal disease in Finland - a modelling approach.

Authors:  Hanna Rinta-Kokko; Markku Nurhonen; Kari Auranen
Journal:  Hum Vaccin Immunother       Date:  2020-12-17       Impact factor: 3.452

6.  Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data.

Authors:  Janepsy Diaz; Solana Terrazas; Ana L Bierrenbach; Cristiana M Toscano; Gizelton P Alencar; Andrés Alvarez; Maria T Valenzuela; Jon Andrus; Roberto del Aguila; Juan C Hormazábal; Pamela Araya; Paola Pidal; Cuauhtemoc R Matus; Lucia H de Oliveira
Journal:  PLoS One       Date:  2016-04-08       Impact factor: 3.240

7.  Micro-scale Spatial Clustering of Cholera Risk Factors in Urban Bangladesh.

Authors:  Qifang Bi; Andrew S Azman; Syed Moinuddin Satter; Azharul Islam Khan; Dilruba Ahmed; Altaf Ahmed Riaj; Emily S Gurley; Justin Lessler
Journal:  PLoS Negl Trop Dis       Date:  2016-02-11

8.  Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil.

Authors:  Eliane Terezinha Afonso; Ruth Minamisava; Ana Luiza Bierrenbach; Juan Jose Cortez Escalante; Airlane Pereira Alencar; Carla Magda Domingues; Otaliba Libanio Morais-Neto; Cristiana Maria Toscano; Ana Lucia Andrade
Journal:  Emerg Infect Dis       Date:  2013-04       Impact factor: 6.883

9.  A sham case-control study of effectiveness of DTP-Hib-hepatitis B vaccine against rotavirus acute gastroenteritis in Kenya.

Authors:  Sammy Khagayi; Jacqueline E Tate; Reuben Onkoba; Umesh Parashar; Frank Odhiambo; Deron Burton; Kayla Laserson; Daniel R Feikin
Journal:  BMC Infect Dis       Date:  2014-02-11       Impact factor: 3.090

10.  Estimating time-varying exposure-outcome associations using case-control data: logistic and case-cohort analyses.

Authors:  Ruth H Keogh; Punam Mangtani; Laura Rodrigues; Patrick Nguipdop Djomo
Journal:  BMC Med Res Methodol       Date:  2016-01-05       Impact factor: 4.615
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.